Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Akampurira

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Medical Microbiology|February 23, 2026
<i>Cryptococcus neoformans</i> responds to presence of <i>Mycobacterium</i> by diversifying its morphologies and remodelling its capsular materialOrlando Ross, Andrew Akampurira, Liliane Mukaremera, et al.
Plos One|July 28, 2017
Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patientsRichard Kwizera, Andrew Akampurira, Darlisha Williams, et al.
Open Forum Infectious Diseases|September 16, 2024
Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained SettingsRichard Kwizera, Tadeo K Kiiza, Andrew Akampurira, et al.
Medical Mycology|December 22, 2025
Analytical validation: Comparison of two laboratory-based methods for CSF quantitative cryptococcal culturesAndrew Akampurira, Thomas C McHale, Tony Luggya, et al.
BMC Microbiology|August 24, 2017
Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitisRichard Kwizera, Andrew Akampurira, Tadeo K Kandole, et al.
Medical Mycology|February 9, 2018
Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluidRichard Kwizera, Andrew Akampurira, Tadeo K Kandole, et al.
Frontiers in Cellular and Infection Microbiology|July 12, 2021
ATI-2307 Exhibits Equivalent Antifungal Activity in <i>Cryptococcus neoformans</i> Clinical Isolates With High and Low Fluconazole IC<sub>50</sub>Elliot S Gerlach, Sophie Altamirano, J Marina Yoder, et al.
Research Square|May 20, 2024
<i>In Vitro</i> Evaluation of the Virulence Attributes of Oropharyngeal <i>Candida</i> Species Isolated from People Living with Human Immunodeficiency Virus with Oropharyngeal Candidiasis on Antiretroviral TherapyBenson Musinguzi, Andrew Akampurira, Hope Derick, et al.
Infection and Immunity|March 6, 2019
The Mouse Inhalation Model of <i>Cryptococcus neoformans</i> Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential VirulenceLiliane Mukaremera, Tami R McDonald, Judith N Nielsen, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in UgandaKyle D Smith, Beatrice Achan, Kathy Huppler Hullsiek, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Medical Microbiology|February 23, 2026
<i>Cryptococcus neoformans</i> responds to presence of <i>Mycobacterium</i> by diversifying its morphologies and remodelling its capsular materialOrlando Ross, Andrew Akampurira, Liliane Mukaremera, et al.
Plos One|July 28, 2017
Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patientsRichard Kwizera, Andrew Akampurira, Darlisha Williams, et al.
Open Forum Infectious Diseases|September 16, 2024
Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained SettingsRichard Kwizera, Tadeo K Kiiza, Andrew Akampurira, et al.
Medical Mycology|December 22, 2025
Analytical validation: Comparison of two laboratory-based methods for CSF quantitative cryptococcal culturesAndrew Akampurira, Thomas C McHale, Tony Luggya, et al.
BMC Microbiology|August 24, 2017
Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitisRichard Kwizera, Andrew Akampurira, Tadeo K Kandole, et al.
Medical Mycology|February 9, 2018
Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluidRichard Kwizera, Andrew Akampurira, Tadeo K Kandole, et al.
Frontiers in Cellular and Infection Microbiology|July 12, 2021
ATI-2307 Exhibits Equivalent Antifungal Activity in <i>Cryptococcus neoformans</i> Clinical Isolates With High and Low Fluconazole IC<sub>50</sub>Elliot S Gerlach, Sophie Altamirano, J Marina Yoder, et al.
Research Square|May 20, 2024
<i>In Vitro</i> Evaluation of the Virulence Attributes of Oropharyngeal <i>Candida</i> Species Isolated from People Living with Human Immunodeficiency Virus with Oropharyngeal Candidiasis on Antiretroviral TherapyBenson Musinguzi, Andrew Akampurira, Hope Derick, et al.
Infection and Immunity|March 6, 2019
The Mouse Inhalation Model of <i>Cryptococcus neoformans</i> Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential VirulenceLiliane Mukaremera, Tami R McDonald, Judith N Nielsen, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in UgandaKyle D Smith, Beatrice Achan, Kathy Huppler Hullsiek, et al.
Pageof 3